Medical weight loss is a supervised obesity treatment plan from a licensed prescriber that may include FDA-approved medicine such as semaglutide or tirzepatide.
Columbus and Franklin County data
Columbus held 938,396 people in July 2025, nearly all of them in Franklin County [5]. Unlike many metros, Columbus has its own CDC PLACES estimate: 34.7% of adults with obesity and 11.8% with diagnosed diabetes in 2023 [4]. Franklin County as a whole reads 33.7% and 11.8% [7]. Only 11.3% of residents are 65 or older [5], so most adults here rely on work coverage or cash rather than Medicare. With a median household income of $66,082 [5], a $349 monthly fill eats roughly 6% of that household's yearly pay.
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Columbus, from $300 a month.
Sponsored listings are paid, labeled and never an endorsement.
The drug bill, before any clinic fee
| Brand | Ingredient | Per month | Ref |
|---|---|---|---|
| Wegovy tablet | Semaglutide | $149 / $199 / $299 by strength | [1] |
| Wegovy weekly pen | Semaglutide | $349 | [1] |
| Zepbound | Tirzepatide | $299 / $399 / $449 by strength | [2] |
| Foundayo tablet | Orforglipron | $149 to $299 | [8] |
Columbus readers comparing brands can go deeper on semaglutide prices, where to fill semaglutide and tirzepatide prices. Every channel side by side: GLP-1 cost comparison.
Hospital programs we could not pin down
We tried to confirm a Columbus hospital weight management program for this update and could not, so none is named. A practical path is to ask your primary care office for an obesity medicine or endocrinology referral. Then ask the program three things: does it prescribe brand drugs, what does a self-pay visit cost, and will it send the prescription to a maker's cash pharmacy.
Ohio licensing and referral rules
Ohio Revised Code 4731.22 gives the medical board grounds to discipline a physician who divides fees for referrals or takes something of value for sending a patient [9]. The board's own site has the license lookup [6]. Treat compounded semaglutide or tirzepatide with care: FDA has not approved these copies and does not test them for safety, effectiveness or quality [10]. Search sellers in our FDA warning letter tracker.
Paying with coverage
- Ohio Medicaid: absent from the obesity-coverage list in KFF's January 2026 count [3].
- Medicare Part D: the GLP-1 Bridge, open July 1, 2026 through December 31, 2027, sets a $50 monthly copay for members who qualify [11].
- Job-based plans: when the plan covers Wegovy, Novo's savings offer can bring the copay down to $25 [1].
Warning signs to act on
Pain high in the belly that is intense and will not settle may be pancreatitis; stop the shots and call. Do the same for hives, lip swelling or wheezing. Anyone also on insulin or a sulfonylurea should know how a low blood sugar feels. In animal studies these drugs caused thyroid C-cell tumors, hence a boxed warning [12][13]. Read the pregnancy section of your label. For an emergency, dial 911.
Other Ohio and Midwest pages
Next door: Cincinnati, Cleveland, Indianapolis and Detroit. For telehealth, see online GLP-1 programs. Start points: the weight loss hub and clinic finder guide.
Questions people ask
What do Columbus residents pay for Wegovy without coverage?
NovoCare listed the Wegovy pen at $349 a month and the tablet at $149 to $299 on October 17, 2026 [1].
Is Zepbound cheaper than Wegovy for a Columbus cash buyer?
Does Ohio Medicaid pay for GLP-1s in Franklin County?
Not for obesity. Ohio was left off KFF's January 2026 list of Medicaid programs covering GLP-1s for weight [3].
How many Columbus adults have obesity?
Where do I confirm an Ohio prescriber's license?
The State Medical Board of Ohio runs the public license lookup for Ohio doctors [6].
Can an Ohio doctor be paid for sending me to a weight clinic?
Ohio Revised Code 4731.22 lets the medical board discipline physicians who split fees for patient referrals or accept anything of value for a referral [9].
Sources
13 cited
- Wegovy self-pay offer. Novo Nordisk (NovoCare), accessed 2026-10-17.
- Zepbound self-pay pricing. Eli Lilly and Company (LillyDirect), accessed 2026-10-17.
- Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
- PLACES place estimates: Columbus city, OH. CDC PLACES (2025 release, BRFSS 2023), 2025 release.
- QuickFacts: Columbus city, Ohio. U.S. Census Bureau, V2025 estimates, accessed 2026-10-17.
- State Medical Board of Ohio. State Medical Board of Ohio, accessed 2026-10-17.
- PLACES county estimates: Franklin County, OH. CDC PLACES (2025 release, BRFSS 2023), 2025 release.
- Foundayo self-pay pricing. Eli Lilly and Company (LillyDirect), accessed 2026-10-17.
- Ohio Rev. Code 4731.22. Ohio Laws and Administrative Rules, accessed 2026-10-17.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
- Weight loss drugs coverage. Medicare.gov, accessed 2026-10-17.
- Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration, Apr 2026.
- Wegovy label. DailyMed, NLM, Jun 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.